Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Blues Group Undecided On Part D Role For 2007; Verdict Depends On OPM

Executive Summary

The BlueCross BlueShield Association's decision about whether to offer Medicare Part D coverage for federal retirees in 2007 will be driven by the Office of Personnel Management

You may also be interested in...

Hatch/Lieberman “BioShield II” Sets 180-Day Window For “Wild Card” Patents

Manufacturers who enter into biodefense contracts must notify the government within 180 days which patent would be covered by a potential "wild card" extension under the final version of "BioShield II" legislation from Sens. Orrin Hatch (R-Utah), Joe Lieberman (D-Conn.) and Sam Brownback (R-Kan.)

Medicare Rx Employer Options Are Flexible But Without Windfalls, CMS Says

The Centers for Medicare & Medicaid Services is waiving several Medicare Part D plan requirements for employers to provide maximum flexibility for their participation in the drug benefit

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts